SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-20-073527
Filing Date
2020-06-16
Accepted
2020-06-16 06:01:17
Documents
6
Effectiveness Date
2020-06-16

Document Format Files

Seq Description Document Type Size
1 DEFR14A tm2012955-3_defr14a.htm DEFR14A 1035820
2 GRAPHIC lg_avadelpharm-4c.jpg GRAPHIC 288581
3 GRAPHIC tm2012955d3_pc1.jpg GRAPHIC 751044
4 GRAPHIC tm2012955d3_pc2.jpg GRAPHIC 496892
5 GRAPHIC tm2012955d3_pc3.jpg GRAPHIC 512545
6 GRAPHIC tm2012955d3_pc4.jpg GRAPHIC 507290
  Complete submission text file 0001104659-20-073527.txt   4536889
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 20964897
SIC: 2834 Pharmaceutical Preparations